Soluble Toll-like receptor 4 is a potential serum biomarker in non-small cell lung cancer.

Oncotarget · 2016 · PMC5129996 · PMID 27223258

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

The results of our present work demonstrated an increasing trend of serum HMGB1 from stage I to stage III in patients with NSCLC without statistical significance.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.